Нашел все-таки в руководстве по STEMI АСС/АНА 2004 ЭКГ-показания к тромолизису
6.3.1.6.3.1. Indications for Fibrinolytic Therapy
Class I
1. In the absence of contraindications, fibrinolytic therapy
should be administered to STEMI patients with
symptom onset within the prior 12 hours and ST elevation
greater than 0.1 mV in at least 2 contiguous
precordial leads or at least 2 adjacent limb leads.
(Level of Evidence: A)
2. In the absence of contraindications, fibrinolytic therapy
should be administered to STEMI patients with
symptom onset within the prior 12 hours and new or
presumably new LBBB. (Level of Evidence: A)
Class IIa
1. In the absence of contraindications, it is reasonable to
administer fibrinolytic therapy to STEMI patients
with symptom onset within the prior 12 hours and 12-
lead ECG findings consistent with a true posterior
MI. (Level of Evidence: C)
2. In the absence of contraindications, it is reasonable to
administer fibrinolytic therapy to patients with symptoms
of STEMI beginning within the prior 12 to 24
hours who have continuing ischemic symptoms and
ST elevation greater than 0.1 mV in at least 2 contiguous
precordial leads or at least 2 adjacent limb leads.
(Level of Evidence: B)
Class III
1. Fibrinolytic therapy should not be administered to
asymptomatic patients whose initial symptoms of
STEMI began more than 24 hours earlier. (Level of
Evidence: C)
2. Fibrinolytic therapy should not be administered to
patients whose 12-lead ECG shows only ST-segment
depression except if a true posterior MI is suspected.
(Level of Evidence: A)
Я позволю себе сделать такое заключение:
Поскольку STEMI определен для показаний к ТЛТ, а показанием к ТЛТ является подЪем ST больше равно 0,1 мВ, считать инфаркт с подъемом ST менее 0,1 мВ nonSTEMI.
(С 6 часов пополудни сего дня считать Катьку девкой (с)).
|